Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the incidence of major vascular events (ischemic or
haemorrhagics) at the third month after initiation of the antithrombotic treatment (oral
anticoagulation or dual antiplatelet therapy) in both arms followed TAVI.